期刊文献+

Nestin及C-kit在胃肠道间质瘤中的表达及意义 被引量:1

The expression of Nestin and C-kit in gastrointestinal stromal tumors
原文传递
导出
摘要 目的观察胃肠道间质瘤(GIST)中Nestin和C-kit在蛋白和转录水平的表达,分析Nestin在GIST诊断、鉴别诊断及发生发展中的意义。方法应用免疫组化、逆转录(RT)-PCR和Western印迹法,检测116例胃肠道间质瘤中Nestin、C-kit的表达(其中22例同时收集新鲜组织),并收集10例正常胃肠道组织和15例平滑肌瘤作为对照。结果116例胃肠道间质瘤中104例(89.7%)Nestin表达阳性;53例良性和63例恶性GIST中分别有47例(88.7%)和57例(90.5%)Nestin表达阳性;Nestin表达水平在良、恶性组间差异无统计学意义(X^2=0.1,P>0.05)。116例GIST中C-kit蛋白的阳性表达率为94.8%(110/116),Nestin和C-kit表达水平间差异无统计学意义(X^2=1.084,P>0.05)。RT-PCR和Western印迹结果显示GIST均有Nestin和C-kit表达。与正常胃肠道组织和平滑肌瘤比较,差异均有统计学意义。结论在GIST中有Nestin高表达,与C-kit联合检测有助于GIST的诊断,但不能作为判断肿瘤危险度的指标。 Objective To investigate the expression of Nestin and C-kit in gastrointestinal stromal tumors and evaluate their role in the diagnosis and pathogenesis of gastrointestinal stromal tumors (GISTs). Methods The expressions of Nestin and C-kit in 116 cases of GISTs were evaluated by immunohistochemistry, RT-PCR and Western-Blot. The result was compared with 15 cases of leiomyomas and 10 cases of normal gastraintestinal tissues. Results Immunohistochemical analysis revealed an over and diffused expression of Nestin in 104 out of the 116 cases of GISTs(89. 7%). The expression of Nestin was positive in 90.5 % of malignant GISTs and 88.7% of benign GISTs with no significance difference between benign and malignant GISTs (Χ^2 = 0.1, P 〉 0.05). The C-kit was expressed in 94.8% (110/ 116) of GISTs. There was no statistical difference between the expression of Nestin and C-kit (Χ^2 = 1. 084, P〉 0.05). The Nestin and C-kit expressions can be detected in all cases of GISTs by RT-PCR and Western Blot. Conclusion In conjunction with C-kit, Nestin may be a useful marker for diagnosis of GISTs but it cannot be used as a tumor differentiation index.
出处 《中华消化杂志》 CAS CSCD 北大核心 2007年第5期314-317,共4页 Chinese Journal of Digestion
关键词 胃肠道间质瘤 诊断 危险度 Gastrointestinal stromal tumors Diagnosis Differential
  • 相关文献

参考文献15

  • 1Mazur MT, Clark HB. Gaslric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol. 1983, 7:507-519.
  • 2Franquemont DW.Differentiation and risk assessment of gastrointestinal stromal tumors.Am J Clin Pathol,1995,103:41-47.
  • 3Hirota S,Isozaki K,Moriyama Y,et al.Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.Science,1998,279:577-580.
  • 4Ernst SI,Hubbs AE,Przygodzki RM,et al.KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors. Lab Invest, 1998, 78:1633-1636.
  • 5刘晓红,马大烈,吴丽莉,白辰光,胡宏杰.原癌基因c-kit在胃肠道间质瘤中的表达及其临床意义[J].中华外科杂志,2002,40(4):277-279. 被引量:29
  • 6Ho CL, Liem RK. Intermediate filaments in the nervous system: implications in cancer. Cancer Metastasis Rev, 1996,15: 483-497.
  • 7Prasad S, Soldatenkov VA, Srinivasarao G, et al. Intermediate filament proteins during carcinogenesis and apoptosis (Review). Int J Oncol, 1999, 14:563-570
  • 8Tsujimura T, Makiishi-Shimobayashi C, Lundkvist J, et al, Expression of the intermediate filament nestin in gastrointestinal stromal tumors and interstitial cells of Cajal. Am J Pathol, 2001, 158:817-823.
  • 9Lendahl U, Zimmerman LB, McKay RD, CNS stem cells express a new class of intermediate filament protein. Cell, 1990, 60:585-595.
  • 10Zimmerman L, Parr B, Lendahl U, et al. Independent regulatory elements in the nestin gene direct transgene expression to neural stem cells or muscle precursors, Neuron, 1994, 12:11-24.

二级参考文献1

共引文献28

同被引文献16

  • 1梁玉梅,李向红,吕有勇,吕亚莉,钟梅,蒲小璐,李文梅.胃肠道间质瘤156例临床病理学特征与预后的分析[J].中华病理学杂志,2007,36(4):233-238. 被引量:15
  • 2郑松,陈丽荣,罗月球,王海军,程水珍,朱永良,周燕.胃肠道间质瘤中c—kit和血小板衍生生长因子受体α基因的突变及其表达研究[J].中华普通外科杂志,2007,22(8):574-578. 被引量:8
  • 3王彦丽,赵向荣,白辰光,杨蕾,马大烈.胃肠道间质瘤组织中PDGFRα和C-kit基因突变和蛋白表达的关系[J].世界华人消化杂志,2007,15(21):2300-2305. 被引量:20
  • 4史恩溢,侯英勇,谭云山,周晓燕,蔡旭,陆永明,朱雄增.局限性胃肠道间质瘤危险程度分级标准的应用与评价[J].中华病理学杂志,2007,36(10):649-653. 被引量:18
  • 5Liegl - Atzwanger B, Fletcher JA, Fletcher CDM. Gastro-intestinal stromal tumors [ J ]. Virchows Arch, 2010, 456 : 111 - 127.
  • 6Tabone - Eglinger S, Subra F, E1 Sayadi H, et al. KIT mu- tations induce intracellular retention and activation of an immature form of the KIT protein in gastrointestinal stromal tumors [ J ]. Clin Cancer Res, 2008, 14 (8) :2285 - 2294.
  • 7Corless CL, Heinrich MC. Molecular pathobiology of gas- trointestinal stromal sarcomas [ J ]. Annu Rev Pathol, 2008,3:557 - 586.
  • 8Liegl - Atzwanger B, Fletcher JA, Fletcher CDM. Gastro- intestinal stromal tumors[ J]. Virchows Arch, 2010, 456 : 111 - 127.
  • 9Corless CL, Fletcher JA, Heinrich MC, et al. Biology of gastrointestinal stromal tumors [ J]. Clin Oncol, 2004,22 (18) :3813 -3825.
  • 10Debiec - Rychter M, Dumez H, Judson I, et al. Use of c -kit/ PDGFRA mutational analysis to predict the clini- cal response to imatinib in patients with advanced gastro- intestinal stromal tumours entered on phase I and II stud- ies of the EORTC Soft Tissue and Bone Sarcoma Group [J]. Cur J Cancer, 2004, 40(5) : 689 -695.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部